Fusen Pharmaceutical Company Limited (HKG:1652)

HKG:1652 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	887	591	591	1,021	1,084	943
Market Cap Growth	306.78%	-	-42.05%	-5.86%	14.94%	-73.09%
Enterprise Value	1,128	906	964	1,249	1,351	1,059
Last Close Price	1.20	0.80	0.80	1.37	1.43	1.23
PE Ratio	-	-	-	-	-	46.17
PS Ratio	2.92	1.94	1.71	1.64	1.95	1.99
PB Ratio	2.23	1.49	1.51	1.65	1.57	1.17
P/TBV Ratio	2.41	1.61	1.63	1.71	1.56	1.17
P/FCF Ratio	-	-	7.64	-	11.07	-
P/OCF Ratio	-	-	4.16	-	8.68	16.09
EV/Sales Ratio	3.71	2.98	2.78	2.01	2.43	2.24
EV/EBITDA Ratio	25.33	31.87	-	22.89	16.52	10.35
EV/EBIT Ratio	190.07	-	-	52.87	26.31	13.09
EV/FCF Ratio	-	-	12.45	-	13.79	-
Debt / Equity Ratio	0.84	0.84	1.05	0.62	0.38	0.38
Debt / EBITDA Ratio	11.79	11.79	-	6.09	2.93	2.79
Debt / FCF Ratio	-	-	5.34	-	2.69	-
Net Debt / Equity Ratio	0.61	0.61	1.00	0.56	0.17	0.26
Net Debt / EBITDA Ratio	8.51	8.51	-11.30	6.33	1.45	2.02
Net Debt / FCF Ratio	-	-	5.05	-3.63	1.21	-2.70
Asset Turnover	0.22	0.22	0.25	0.42	0.38	0.31
Inventory Turnover	1.30	1.30	0.97	1.73	2.11	1.48
Quick Ratio	0.24	0.24	0.36	0.50	0.61	0.70
Current Ratio	0.56	0.56	0.60	0.85	0.85	1.04
Return on Equity (ROE)	-3.25%	-3.25%	-40.58%	-6.18%	-5.46%	2.53%
Return on Assets (ROA)	-0.46%	-0.46%	-3.25%	1.00%	2.19%	3.32%
Return on Invested Capital (ROIC)	-1.59%	-1.39%	-8.34%	2.69%	5.88%	6.72%
Return on Capital Employed (ROCE)	-2.40%	-2.40%	-14.40%	3.20%	7.20%	8.80%
Earnings Yield	-1.48%	-2.22%	-33.97%	-3.92%	-3.61%	2.17%
FCF Yield	-	-	13.09%	-9.33%	9.03%	-8.12%
Dividend Yield	-	-	-	-	-	0.91%
Payout Ratio	-	-	-	-	-	49.90%
Buyback Yield / Dilution	0.09%	0.09%	1.60%	0.53%	1.85%	2.51%
Total Shareholder Return	0.09%	0.09%	1.60%	0.53%	1.85%	3.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.